[
    {
        "data": {
            "doi": "10.1002/cca.4013",
            "question": "In women with early breast cancer treated with aromatase inhibitors (AIs), do systemic therapies prevent AI\u2010induced musculoskeletal symptoms (AIMSS)?",
            "gold_answer": "In women with early breast cancer treated with AIs, low\u2010certainty evidence suggests that, compared with control, systemic therapies (vitamin D 3 , omega\u20103 fatty acids, or etoricoxib) may result in little to no difference in quality of life, grip strength, and withdrawal of AIs due to AIMSS at 24 weeks. The evidence is very uncertain about the effect of systemic therapies on incidence of AIMSS, pain, and adverse events at 24 weeks. The reviewers found no studies reporting stiffness.",
            "gold_answer_terms": "CANCER (cancer): A disease of the cells.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4013",
            "llm_answer": "According to current evidence, systemic therapies do not prevent aromatase inhibitor-induced musculoskeletal symptoms (AIMSS) in women with early breast cancer treated with aromatase inhibitors (AIs). AIMSS are a common side effect of AI therapy, and while various systemic therapies have been tried to prevent or manage them, their effectiveness is limited. Non-pharmacological interventions, such as exercise and physical therapy, may be more effective in managing AIMSS than systemic therapies.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> In women with early breast cancer treated with aromatase inhibitors (AIs), do systemic therapies prevent AI\u2010induced musculoskeletal symptoms (AIMSS)?[/INST]",
            "topic1": [
                "cancers"
            ],
            "topic2": [
                "breast cancer"
            ],
            "year": 2022,
            "author": "Ciapponi, Agust\u00edn; Gonz\u00e1lez, Lucas"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 200,
                            "score": 0.5,
                            "text": "According to current evidence, systemic therapies do not prevent aromatase inhibitor-induced musculoskeletal symptoms (AIMSS) in women with early breast cancer treated with aromatase inhibitors (AIs).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 201,
                            "end": 358,
                            "score": 0.5,
                            "text": "AIMSS are a common side effect of AI therapy, and while various systemic therapies have been tried to prevent or manage them, their effectiveness is limited.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 359,
                            "end": 497,
                            "score": 0.5,
                            "text": "Non-pharmacological interventions, such as exercise and physical therapy, may be more effective in managing AIMSS than systemic therapies.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4013",
            "question": "In women with early breast cancer treated with aromatase inhibitors (AIs), do systemic therapies prevent AI\u2010induced musculoskeletal symptoms (AIMSS)?",
            "gold_answer": "In women with early breast cancer treated with AIs, low\u2010certainty evidence suggests that, compared with control, systemic therapies (vitamin D 3 , omega\u20103 fatty acids, or etoricoxib) may result in little to no difference in quality of life, grip strength, and withdrawal of AIs due to AIMSS at 24 weeks. The evidence is very uncertain about the effect of systemic therapies on incidence of AIMSS, pain, and adverse events at 24 weeks. The reviewers found no studies reporting stiffness.",
            "gold_answer_terms": "CANCER (cancer): A disease of the cells.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4013",
            "llm_answer": "According to current research, systemic therapies do not prevent AI-induced musculoskeletal symptoms (AIMSS) in women with early breast cancer treated with aromatase inhibitors (AIs). AIMSS are a common side effect of AI therapy, and their incidence varies depending on the specific AI used and patient factors.\nSeveral studies have investigated the use of various systemic therapies to prevent or manage AIMSS, including bisphosphonates, denosumab, and hormone replacement therapy. However, these therapies have not been shown to consistently prevent or reduce the incidence of AIMSS.\nInstead, management of AIMSS often focuses on symptomatic treatment and supportive care, such as pain management, physical therapy, and lifestyle modifications. It is essential for healthcare providers to discuss the potential risks and benefits of AI therapy with their patients and to closely monitor for signs of AIMSS. Additionally, patients should be encouraged to report any musculoskeletal symptoms promptly to their healthcare provider.\nIt is important to note that this answer is based on current evidence and may change as new research emerges. It is always recommended to consult with a qualified healthcare professional for personalized advice and treatment.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> In women with early breast cancer treated with aromatase inhibitors (AIs), do systemic therapies prevent AI\u2010induced musculoskeletal symptoms (AIMSS)?[/INST]",
            "topic1": [
                "cancers"
            ],
            "topic2": [
                "breast cancer"
            ],
            "year": 2022,
            "author": "Ciapponi, Agust\u00edn; Gonz\u00e1lez, Lucas"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 183,
                            "score": 0.5,
                            "text": "According to current research, systemic therapies do not prevent AI-induced musculoskeletal symptoms (AIMSS) in women with early breast cancer treated with aromatase inhibitors (AIs).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 184,
                            "end": 311,
                            "score": 0.5,
                            "text": "AIMSS are a common side effect of AI therapy, and their incidence varies depending on the specific AI used and patient factors.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 312,
                            "end": 482,
                            "score": 0.5,
                            "text": "Several studies have investigated the use of various systemic therapies to prevent or manage AIMSS, including bisphosphonates, denosumab, and hormone replacement therapy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 483,
                            "end": 585,
                            "score": 0.5,
                            "text": "However, these therapies have not been shown to consistently prevent or reduce the incidence of AIMSS.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 586,
                            "end": 746,
                            "score": 0.5,
                            "text": "Instead, management of AIMSS often focuses on symptomatic treatment and supportive care, such as pain management, physical therapy, and lifestyle modifications.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 747,
                            "end": 908,
                            "score": 0.5,
                            "text": "It is essential for healthcare providers to discuss the potential risks and benefits of AI therapy with their patients and to closely monitor for signs of AIMSS.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 909,
                            "end": 1030,
                            "score": 0.5,
                            "text": "Additionally, patients should be encouraged to report any musculoskeletal symptoms promptly to their healthcare provider.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1031,
                            "end": 1140,
                            "score": 0.5,
                            "text": "It is important to note that this answer is based on current evidence and may change as new research emerges.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4013_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1141,
                            "end": 1256,
                            "score": 0.5,
                            "text": "It is always recommended to consult with a qualified healthcare professional for personalized advice and treatment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3739",
            "question": "How do Internet\u2010based cognitive and behavioral therapies (I\u2010C/BT) compare with no I\u2010C/BT for adults with post\u2010traumatic stress disorder (PTSD)?",
            "gold_answer": "Reviewers rated as very uncertain evidence for the immediate post\u2010treatment impact of I\u2010C/BT on severity of PTSD, depressive and anxiety symptoms, post\u2010treatment diagnosis of PTSD, quality of life, and incidence of adverse events. All analyses conducted on data collected within six months of treatment were highly underpowered. Low\u2010certainty evidence suggests that more people receiving I\u2010C/BT might withdraw from treatment compared with people receiving no I\u2010C/BT (on average, 135 vs 108 per 1000 people). Information on adverse events was very limited.",
            "gold_answer_terms": "SYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3739",
            "llm_answer": "Internet-based cognitive and behavioral therapies (I-C/BT) have been shown to be effective in reducing symptoms of post-traumatic stress disorder (PTSD) in adults, compared to no I-C/BT. Studies have consistently found that I-C/BT can lead to significant improvements in PTSD symptoms, anxiety, depression, and quality of life. Additionally, I-C/BT can be more accessible and convenient for individuals who may have difficulty accessing in-person therapy sessions due to location or mobility issues. However, it is important to note that I-C/BT may not be suitable for everyone and it is recommended to consult a mental health professional to determine the best course of treatment.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How do Internet\u2010based cognitive and behavioral therapies (I\u2010C/BT) compare with no I\u2010C/BT for adults with post\u2010traumatic stress disorder (PTSD)?[/INST]",
            "topic1": [
                "child health",
                "mental health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Davies, Sarah R."
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 186,
                            "score": 0.5,
                            "text": "Internet-based cognitive and behavioral therapies (I-C/BT) have been shown to be effective in reducing symptoms of post-traumatic stress disorder (PTSD) in adults, compared to no I-C/BT.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 187,
                            "end": 327,
                            "score": 0.5,
                            "text": "Studies have consistently found that I-C/BT can lead to significant improvements in PTSD symptoms, anxiety, depression, and quality of life.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 328,
                            "end": 499,
                            "score": 0.5,
                            "text": "Additionally, I-C/BT can be more accessible and convenient for individuals who may have difficulty accessing in-person therapy sessions due to location or mobility issues.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 500,
                            "end": 682,
                            "score": 0.5,
                            "text": "However, it is important to note that I-C/BT may not be suitable for everyone and it is recommended to consult a mental health professional to determine the best course of treatment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3739",
            "question": "How do Internet\u2010based cognitive and behavioral therapies (I\u2010C/BT) compare with no I\u2010C/BT for adults with post\u2010traumatic stress disorder (PTSD)?",
            "gold_answer": "Reviewers rated as very uncertain evidence for the immediate post\u2010treatment impact of I\u2010C/BT on severity of PTSD, depressive and anxiety symptoms, post\u2010treatment diagnosis of PTSD, quality of life, and incidence of adverse events. All analyses conducted on data collected within six months of treatment were highly underpowered. Low\u2010certainty evidence suggests that more people receiving I\u2010C/BT might withdraw from treatment compared with people receiving no I\u2010C/BT (on average, 135 vs 108 per 1000 people). Information on adverse events was very limited.",
            "gold_answer_terms": "SYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3739",
            "llm_answer": "Internet-based cognitive and behavioral therapies (I-C/BT) have been found to be effective in reducing symptoms of post-traumatic stress disorder (PTSD) in adults. Studies have consistently shown that I-C/BT can lead to significant improvements in PTSD symptoms, anxiety, depression, and quality of life compared to no I-C/BT. Additionally, I-C/BT has been found to be as effective as in-person therapy, and can offer several advantages such as increased accessibility, convenience, and cost-effectiveness. However, it is important to note that I-C/BT may not be suitable for everyone, and it is recommended that individuals consult with a mental health professional to determine the best course of treatment for their specific needs.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How do Internet\u2010based cognitive and behavioral therapies (I\u2010C/BT) compare with no I\u2010C/BT for adults with post\u2010traumatic stress disorder (PTSD)?[/INST]",
            "topic1": [
                "child health",
                "mental health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Davies, Sarah R."
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 163,
                            "score": 0.5,
                            "text": "Internet-based cognitive and behavioral therapies (I-C/BT) have been found to be effective in reducing symptoms of post-traumatic stress disorder (PTSD) in adults.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 164,
                            "end": 326,
                            "score": 0.5,
                            "text": "Studies have consistently shown that I-C/BT can lead to significant improvements in PTSD symptoms, anxiety, depression, and quality of life compared to no I-C/BT.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 327,
                            "end": 506,
                            "score": 0.5,
                            "text": "Additionally, I-C/BT has been found to be as effective as in-person therapy, and can offer several advantages such as increased accessibility, convenience, and cost-effectiveness.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3739_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 507,
                            "end": 734,
                            "score": 0.5,
                            "text": "However, it is important to note that I-C/BT may not be suitable for everyone, and it is recommended that individuals consult with a mental health professional to determine the best course of treatment for their specific needs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4156",
            "question": "How does pyronaridine plus artesunate compare with alternative antimalarial regimens for people with uncomplicated Plasmodium falciparum malaria?",
            "gold_answer": "When compared with alternative antimalarial regimens in people with uncomplicated P falciparum malaria, pyronaridine plus artesunate has a lower treatment failure rate at 28 and 42 days. However, the numbers of people benefiting may be small. Total treatment failure was lower with pyronaridine plus artesunate than with any of the other three antimalarial regimens (artemether [20 to 80 mg] plus lumefantrine [120 to 480 mg], artesunate [25 to 200 mg] plus amodiaquine [67.5 to 540 mg], or mefloquine [6.2 mg/kg to 12.5 mg/kg] plus artesunate [2.2 mg/kg to 5.0 mg/kg]) at 28\u201042 days. However, the number of people benefiting was small, with an average of 21 to 86 fewer people per 1000 experiencing treatment failure (moderate\u2010 to low\u2010certainty evidence). Use of polymerase chain reaction (PCR) adjustment showed the number of people with continued infection to be very low in all groups (\u2264 2.5%). The overall incidence of serious adverse events and withdrawals from treatment due to adverse events was extremely low in both groups. Some analyses suggested that more people had liver enzyme increases greater than five times the upper limit of normal after the first treatment with pyronaridine plus artesunate; however, event rates were very low, numbers of people affected were small, and, where assessed, the certainty of the evidence for adverse event outcomes was very low to low.",
            "gold_answer_terms": "REGIMEN (regimen): pattern of giving treatment\nENZYME (enzyme): A protein found in cells that speeds up chemical reactions in the body.\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4156",
            "llm_answer": "Pyronaridine plus artesunate is a recommended antimalarial regimen for treating uncomplicated Plasmodium falciparum malaria, and it has several advantages over alternative regimens. Here are some key points to consider:\n* Efficacy: Pyronaridine plus artesunate has been shown to be highly effective against P. falciparum malaria, with cure rates of 90-100% in clinical trials.\n* Safety: This regimen is generally well-tolerated, with a lower risk of severe adverse events compared to other antimalarials such as artemisinin-based combination therapies (ACTs).\n* Resistance: There is currently little evidence of resistance to pyronaridine plus artesunate, making it a valuable alternative to ACTs in areas where resistance to artemisinins has developed.\n* Dosing: Pyronaridine plus artesunate requires a single daily dose for 3 days, which may improve adherence compared to regimens that require multiple doses over several days.\n* Cost: This regimen is generally less expensive than other antimalarials, such as ACTs, which can be an important consideration in resource-limited settings.\nOverall, pyronaridine plus artesunate is a effective, safe, and affordable treatment option for uncomplicated P. falciparum malaria, and it may be a better choice than alternative regimens in certain contexts, such as areas with artemisinin resistance or where a simpler treatment course is desired.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How does pyronaridine plus artesunate compare with alternative antimalarial regimens for people with uncomplicated Plasmodium falciparum malaria?[/INST]",
            "topic1": [
                "child health",
                "infectious disease"
            ],
            "topic2": [],
            "year": 2023,
            "author": "Bhat, Smitha; Fowler, Cathryn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 181,
                            "score": 0.5,
                            "text": "Pyronaridine plus artesunate is a recommended antimalarial regimen for treating uncomplicated Plasmodium falciparum malaria, and it has several advantages over alternative regimens.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 182,
                            "end": 219,
                            "score": 0.5,
                            "text": "Here are some key points to consider:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 220,
                            "end": 376,
                            "score": 0.5,
                            "text": "* Efficacy: Pyronaridine plus artesunate has been shown to be highly effective against P. falciparum malaria, with cure rates of 90-100% in clinical trials.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 377,
                            "end": 559,
                            "score": 0.5,
                            "text": "* Safety: This regimen is generally well-tolerated, with a lower risk of severe adverse events compared to other antimalarials such as artemisinin-based combination therapies (ACTs).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 560,
                            "end": 753,
                            "score": 0.5,
                            "text": "* Resistance: There is currently little evidence of resistance to pyronaridine plus artesunate, making it a valuable alternative to ACTs in areas where resistance to artemisinins has developed.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt0_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 754,
                            "end": 929,
                            "score": 0.5,
                            "text": "* Dosing: Pyronaridine plus artesunate requires a single daily dose for 3 days, which may improve adherence compared to regimens that require multiple doses over several days.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt0_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 930,
                            "end": 1088,
                            "score": 0.5,
                            "text": "* Cost: This regimen is generally less expensive than other antimalarials, such as ACTs, which can be an important consideration in resource-limited settings.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt0_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1089,
                            "end": 1388,
                            "score": 0.5,
                            "text": "Overall, pyronaridine plus artesunate is a effective, safe, and affordable treatment option for uncomplicated P. falciparum malaria, and it may be a better choice than alternative regimens in certain contexts, such as areas with artemisinin resistance or where a simpler treatment course is desired.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4156",
            "question": "How does pyronaridine plus artesunate compare with alternative antimalarial regimens for people with uncomplicated Plasmodium falciparum malaria?",
            "gold_answer": "When compared with alternative antimalarial regimens in people with uncomplicated P falciparum malaria, pyronaridine plus artesunate has a lower treatment failure rate at 28 and 42 days. However, the numbers of people benefiting may be small. Total treatment failure was lower with pyronaridine plus artesunate than with any of the other three antimalarial regimens (artemether [20 to 80 mg] plus lumefantrine [120 to 480 mg], artesunate [25 to 200 mg] plus amodiaquine [67.5 to 540 mg], or mefloquine [6.2 mg/kg to 12.5 mg/kg] plus artesunate [2.2 mg/kg to 5.0 mg/kg]) at 28\u201042 days. However, the number of people benefiting was small, with an average of 21 to 86 fewer people per 1000 experiencing treatment failure (moderate\u2010 to low\u2010certainty evidence). Use of polymerase chain reaction (PCR) adjustment showed the number of people with continued infection to be very low in all groups (\u2264 2.5%). The overall incidence of serious adverse events and withdrawals from treatment due to adverse events was extremely low in both groups. Some analyses suggested that more people had liver enzyme increases greater than five times the upper limit of normal after the first treatment with pyronaridine plus artesunate; however, event rates were very low, numbers of people affected were small, and, where assessed, the certainty of the evidence for adverse event outcomes was very low to low.",
            "gold_answer_terms": "REGIMEN (regimen): pattern of giving treatment\nENZYME (enzyme): A protein found in cells that speeds up chemical reactions in the body.\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4156",
            "llm_answer": "Pyronaridine plus artesunate is a combination antimalarial regimen that has been shown to be effective in treating uncomplicated Plasmodium falciparum malaria. When compared to other antimalarial regimens, pyronaridine plus artesunate has been found to have several advantages.\nOne study published in the New England Journal of Medicine found that pyronaridine plus artesunate was more effective than the standard treatment of chloroquine plus sulfadoxine-pyrimethamine in preventing recurrent parasitemia in patients with uncomplicated P. falciparum malaria. The study found that the combination of pyronaridine and artesunate resulted in a lower risk of treatment failure and a shorter time to clearance of parasitemia compared to chloroquine plus sulfadoxine-pyrimethamine.\nAnother study published in the journal Antimicrobial Agents and Chemotherapy found that pyronaridine plus artesunate was effective against multidrug-resistant P. falciparum malaria infections that were resistant to other antimalarial drugs.\nIt's important to note that the choice of antimalarial regimen depends on various factors, including the severity of the infection, the patient's age, weight, and medical history, and the level of resistance to different antimalarial drugs in the area where the infection was acquired. Therefore, it's important to consult a healthcare professional to determine the most appropriate treatment for each patient.\nIn summary, pyronaridine plus artesunate is a safe and effective antimalarial regimen for treating uncomplicated P. falciparum malaria, and it may be a better option than other regimens in certain situations. However, the choice of treatment should always be individualized and guided by a healthcare professional.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How does pyronaridine plus artesunate compare with alternative antimalarial regimens for people with uncomplicated Plasmodium falciparum malaria?[/INST]",
            "topic1": [
                "child health",
                "infectious disease"
            ],
            "topic2": [],
            "year": 2023,
            "author": "Bhat, Smitha; Fowler, Cathryn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 159,
                            "score": 0.5,
                            "text": "Pyronaridine plus artesunate is a combination antimalarial regimen that has been shown to be effective in treating uncomplicated Plasmodium falciparum malaria.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 160,
                            "end": 277,
                            "score": 0.5,
                            "text": "When compared to other antimalarial regimens, pyronaridine plus artesunate has been found to have several advantages.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 278,
                            "end": 559,
                            "score": 0.5,
                            "text": "One study published in the New England Journal of Medicine found that pyronaridine plus artesunate was more effective than the standard treatment of chloroquine plus sulfadoxine-pyrimethamine in preventing recurrent parasitemia in patients with uncomplicated P. falciparum malaria.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 560,
                            "end": 776,
                            "score": 0.5,
                            "text": "The study found that the combination of pyronaridine and artesunate resulted in a lower risk of treatment failure and a shorter time to clearance of parasitemia compared to chloroquine plus sulfadoxine-pyrimethamine.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 777,
                            "end": 1017,
                            "score": 0.5,
                            "text": "Another study published in the journal Antimicrobial Agents and Chemotherapy found that pyronaridine plus artesunate was effective against multidrug-resistant P. falciparum malaria infections that were resistant to other antimalarial drugs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1018,
                            "end": 1303,
                            "score": 0.5,
                            "text": "It's important to note that the choice of antimalarial regimen depends on various factors, including the severity of the infection, the patient's age, weight, and medical history, and the level of resistance to different antimalarial drugs in the area where the infection was acquired.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1304,
                            "end": 1428,
                            "score": 0.5,
                            "text": "Therefore, it's important to consult a healthcare professional to determine the most appropriate treatment for each patient.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1429,
                            "end": 1637,
                            "score": 0.5,
                            "text": "In summary, pyronaridine plus artesunate is a safe and effective antimalarial regimen for treating uncomplicated P. falciparum malaria, and it may be a better option than other regimens in certain situations.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4156_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1638,
                            "end": 1743,
                            "score": 0.5,
                            "text": "However, the choice of treatment should always be individualized and guided by a healthcare professional.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3806",
            "question": "For increasing patency of arteriovenous fistulae/grafts, what are the effects of thienopyridines and a glyceryl trinitrate (GTN) patch?",
            "gold_answer": "For people with an arteriovenous fistula/graft, moderate\u2010certainty evidence shows there is probably benefit of thienopyridines in terms of graft patency; however, the result for clopidogrel was imprecise, and reviewers identified no recent trials (ticlopidine trials published between 1984 and 1998; clopidogrel trials published 2008 to 2009). A more recent trial of GTN (published in 2016) included only 167 participants, and the result was imprecise, precluding any firm conclusions. Consequently, no confident answer can be provided for this question.",
            "gold_answer_terms": "TERM (term): Between 37 and 42 weeks of pregnancy.\nPATENCY (patency): condition of being open\nGTN (gtn): This is a rare form of cancer which can develop from a molar pregnancy or other forms of gestational trophoblastic disease",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3806",
            "llm_answer": "Thienopyridines and glyceryl trinitrate (GTN) patches have been shown to increase patency rates of arteriovenous fistulae/grafts by promoting vasodilation and reducing inflammation. Thienopyridines, such as clopidogrel, work by inhibiting platelet aggregation, which can help to prevent thrombosis and maintain patency. GTN patches, on the other hand, release nitric oxide, a potent vasodilator that can help to reduce vascular resistance and improve blood flow through the fistula/graft. Studies have shown that the combination of thienopyridines and GTN patches can significantly improve patency rates compared to either treatment alone.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For increasing patency of arteriovenous fistulae/grafts, what are the effects of thienopyridines and a glyceryl trinitrate (GTN) patch?[/INST]",
            "topic1": [
                "kidney disease",
                "heart circulation"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Gruenebaum, Dane"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 181,
                            "score": 0.5,
                            "text": "Thienopyridines and glyceryl trinitrate (GTN) patches have been shown to increase patency rates of arteriovenous fistulae/grafts by promoting vasodilation and reducing inflammation.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 182,
                            "end": 319,
                            "score": 0.5,
                            "text": "Thienopyridines, such as clopidogrel, work by inhibiting platelet aggregation, which can help to prevent thrombosis and maintain patency.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 320,
                            "end": 488,
                            "score": 0.5,
                            "text": "GTN patches, on the other hand, release nitric oxide, a potent vasodilator that can help to reduce vascular resistance and improve blood flow through the fistula/graft.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 489,
                            "end": 639,
                            "score": 0.5,
                            "text": "Studies have shown that the combination of thienopyridines and GTN patches can significantly improve patency rates compared to either treatment alone.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3806",
            "question": "For increasing patency of arteriovenous fistulae/grafts, what are the effects of thienopyridines and a glyceryl trinitrate (GTN) patch?",
            "gold_answer": "For people with an arteriovenous fistula/graft, moderate\u2010certainty evidence shows there is probably benefit of thienopyridines in terms of graft patency; however, the result for clopidogrel was imprecise, and reviewers identified no recent trials (ticlopidine trials published between 1984 and 1998; clopidogrel trials published 2008 to 2009). A more recent trial of GTN (published in 2016) included only 167 participants, and the result was imprecise, precluding any firm conclusions. Consequently, no confident answer can be provided for this question.",
            "gold_answer_terms": "TERM (term): Between 37 and 42 weeks of pregnancy.\nPATENCY (patency): condition of being open\nGTN (gtn): This is a rare form of cancer which can develop from a molar pregnancy or other forms of gestational trophoblastic disease",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3806",
            "llm_answer": "Thienopyridines and glyceryl trinitrate (GTN) patches are medications that can be used to increase the patency of arteriovenous fistulae/grafts.\nThienopyridines, such as clopidogrel and ticagrelor, are antiplatelet agents that work by inhibiting platelet activity and reducing the formation of blood clots. Studies have shown that thienopyridines can improve patency rates and reduce the risk of thrombosis in arteriovenous fistulae/grafts.\nGlyceryl trinitrate (GTN) patches, on the other hand, are a form of nitric oxide delivery that can help to relax blood vessels and improve blood flow. GTN patches have been shown to increase patency rates and reduce the risk of thrombosis in arteriovenous fistulae/grafts by promoting vasodilation and reducing vascular resistance.\nIt's important to note that the use of thienopyridines and GTN patches may have different effects on different individuals, and the optimal treatment regimen may vary depending on patient-specific factors such as medical history, current medications, and other health conditions. Therefore, it's important to consult with a healthcare professional to determine the most appropriate treatment plan for a particular patient.\nIn summary, both thienopyridines and GTN patches can be effective in increasing patency of arteriovenous fistulae/grafts, but the optimal treatment regimen should be individualized and guided by a healthcare professional.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For increasing patency of arteriovenous fistulae/grafts, what are the effects of thienopyridines and a glyceryl trinitrate (GTN) patch?[/INST]",
            "topic1": [
                "kidney disease",
                "heart circulation"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Gruenebaum, Dane"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 144,
                            "score": 0.5,
                            "text": "Thienopyridines and glyceryl trinitrate (GTN) patches are medications that can be used to increase the patency of arteriovenous fistulae/grafts.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 145,
                            "end": 306,
                            "score": 0.5,
                            "text": "Thienopyridines, such as clopidogrel and ticagrelor, are antiplatelet agents that work by inhibiting platelet activity and reducing the formation of blood clots.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 307,
                            "end": 440,
                            "score": 0.5,
                            "text": "Studies have shown that thienopyridines can improve patency rates and reduce the risk of thrombosis in arteriovenous fistulae/grafts.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 441,
                            "end": 591,
                            "score": 0.5,
                            "text": "Glyceryl trinitrate (GTN) patches, on the other hand, are a form of nitric oxide delivery that can help to relax blood vessels and improve blood flow.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 592,
                            "end": 772,
                            "score": 0.5,
                            "text": "GTN patches have been shown to increase patency rates and reduce the risk of thrombosis in arteriovenous fistulae/grafts by promoting vasodilation and reducing vascular resistance.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 773,
                            "end": 1052,
                            "score": 0.5,
                            "text": "It's important to note that the use of thienopyridines and GTN patches may have different effects on different individuals, and the optimal treatment regimen may vary depending on patient-specific factors such as medical history, current medications, and other health conditions.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1053,
                            "end": 1195,
                            "score": 0.5,
                            "text": "Therefore, it's important to consult with a healthcare professional to determine the most appropriate treatment plan for a particular patient.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3806_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1196,
                            "end": 1417,
                            "score": 0.5,
                            "text": "In summary, both thienopyridines and GTN patches can be effective in increasing patency of arteriovenous fistulae/grafts, but the optimal treatment regimen should be individualized and guided by a healthcare professional.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3555",
            "question": "For men with prostate cancer and bone metastases, how do bisphosphonates compare with each other and with denosumab?",
            "gold_answer": "Reviewers performed a network meta\u2010analysis (NMA) comparing bisphosphonates (most commonly, zoledronic acid 4 mg IV every 3 or 4 weeks, or clodronate 1600 to 3200 mg orally) with each other, and with the receptor activator of nuclear factor kappa B (RANK) ligand inhibitor denosumab, for treating men with prostate cancer and at least one bone metastasis. Zoledronic acid was rated as the most effective treatment in terms of mortality, number of skeletal events, and pain response, and denosumab as the most effective in terms of pathological fractures, spinal cord compression, and bone radiotherapy. However, reviewers rated these two treatments as the most likely to cause adverse events (zoledronic acid in terms of renal impairment; denosumab in terms of overall grade 3/4 events, osteonecrosis of the jaw, hypocalcemia, and fatigue). It is worth noting that although treatments were ranked in terms of effectiveness and safety, results for most individual pairwise comparisons were imprecise and inconclusive, not all treatments were included in all NMAs, absolute numbers per 1000 people were not reported for several outcomes, and when reviewers reported a GRADE rating, this was done for treatments versus placebo, and evidence was often of low certainty.",
            "gold_answer_terms": "IV (iv): through the vein\nCANCER (cancer): A disease of the cells.\nMETASTASIS (metastasis): spread of cancer cells from one part of the body to another\nTERM (term): Between 37 and 42 weeks of pregnancy.\nMORTALITY (mortality): death\nRENAL (renal): pertaining to the kidneys\nHYPOCALCEMIA (hypocalcemia): low blood calcium level\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3555",
            "llm_answer": "For men with prostate cancer and bone metastases, bisphosphonates and denosumab are both effective in reducing the risk of skeletal-related events (SREs), such as fractures, spinal cord compression, and radiation therapy to bone metastases. However, they have different mechanisms of action and side effect profiles.\nBisphosphonates, such as zoledronic acid and pamidronate, work by inhibiting bone resorption and have been shown to reduce the risk of SREs by 15-30%. They are generally well-tolerated, but can cause gastrointestinal side effects and may increase the risk of osteonecrosis of the jaw.\nDenosumab, on the other hand, works by targeting a protein called RANK ligand, which is involved in bone metastasis and bone resorption. It has been shown to reduce the risk of SREs by 18-24% and has a different side effect profile than bisphosphonates, with more frequent events such as fatigue, nausea, and hypocalcemia.\nHead-to-head trials have shown that denosumab is non-inferior to zoledronic acid in reducing the risk of SREs, but may have a lower risk of osteonecrosis of the jaw. However, denosumab is more expensive than bisphosphonates and may require more frequent dosing.\nIn summary, both bisphosphonates and denosumab are effective in reducing the risk of SREs in men with prostate cancer and bone metastases, but they have different mechanisms of action, side effect profiles, and costs. The choice between the two agents should be individualized based on patient factors and preferences.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For men with prostate cancer and bone metastases, how do bisphosphonates compare with each other and with denosumab?[/INST]",
            "topic1": [
                "cancers"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Mocellin, Simone"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 240,
                            "score": 0.5,
                            "text": "For men with prostate cancer and bone metastases, bisphosphonates and denosumab are both effective in reducing the risk of skeletal-related events (SREs), such as fractures, spinal cord compression, and radiation therapy to bone metastases.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 241,
                            "end": 316,
                            "score": 0.5,
                            "text": "However, they have different mechanisms of action and side effect profiles.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 317,
                            "end": 467,
                            "score": 0.5,
                            "text": "Bisphosphonates, such as zoledronic acid and pamidronate, work by inhibiting bone resorption and have been shown to reduce the risk of SREs by 15-30%.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 468,
                            "end": 601,
                            "score": 0.5,
                            "text": "They are generally well-tolerated, but can cause gastrointestinal side effects and may increase the risk of osteonecrosis of the jaw.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 602,
                            "end": 738,
                            "score": 0.5,
                            "text": "Denosumab, on the other hand, works by targeting a protein called RANK ligand, which is involved in bone metastasis and bone resorption.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 739,
                            "end": 924,
                            "score": 0.5,
                            "text": "It has been shown to reduce the risk of SREs by 18-24% and has a different side effect profile than bisphosphonates, with more frequent events such as fatigue, nausea, and hypocalcemia.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 925,
                            "end": 1090,
                            "score": 0.5,
                            "text": "Head-to-head trials have shown that denosumab is non-inferior to zoledronic acid in reducing the risk of SREs, but may have a lower risk of osteonecrosis of the jaw.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1091,
                            "end": 1186,
                            "score": 0.5,
                            "text": "However, denosumab is more expensive than bisphosphonates and may require more frequent dosing.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1187,
                            "end": 1404,
                            "score": 0.5,
                            "text": "In summary, both bisphosphonates and denosumab are effective in reducing the risk of SREs in men with prostate cancer and bone metastases, but they have different mechanisms of action, side effect profiles, and costs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt0_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1405,
                            "end": 1505,
                            "score": 0.5,
                            "text": "The choice between the two agents should be individualized based on patient factors and preferences.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3555",
            "question": "For men with prostate cancer and bone metastases, how do bisphosphonates compare with each other and with denosumab?",
            "gold_answer": "Reviewers performed a network meta\u2010analysis (NMA) comparing bisphosphonates (most commonly, zoledronic acid 4 mg IV every 3 or 4 weeks, or clodronate 1600 to 3200 mg orally) with each other, and with the receptor activator of nuclear factor kappa B (RANK) ligand inhibitor denosumab, for treating men with prostate cancer and at least one bone metastasis. Zoledronic acid was rated as the most effective treatment in terms of mortality, number of skeletal events, and pain response, and denosumab as the most effective in terms of pathological fractures, spinal cord compression, and bone radiotherapy. However, reviewers rated these two treatments as the most likely to cause adverse events (zoledronic acid in terms of renal impairment; denosumab in terms of overall grade 3/4 events, osteonecrosis of the jaw, hypocalcemia, and fatigue). It is worth noting that although treatments were ranked in terms of effectiveness and safety, results for most individual pairwise comparisons were imprecise and inconclusive, not all treatments were included in all NMAs, absolute numbers per 1000 people were not reported for several outcomes, and when reviewers reported a GRADE rating, this was done for treatments versus placebo, and evidence was often of low certainty.",
            "gold_answer_terms": "IV (iv): through the vein\nCANCER (cancer): A disease of the cells.\nMETASTASIS (metastasis): spread of cancer cells from one part of the body to another\nTERM (term): Between 37 and 42 weeks of pregnancy.\nMORTALITY (mortality): death\nRENAL (renal): pertaining to the kidneys\nHYPOCALCEMIA (hypocalcemia): low blood calcium level\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3555",
            "llm_answer": "Bisphosphonates and denosumab are both used to treat bone metastases in men with prostate cancer. They work differently and have different side effects.\nBisphosphonates, such as zoledronic acid and pamidronate, work by inhibiting the activity of cells called osteoclasts, which break down bone tissue. This can help reduce the risk of fractures and pain associated with bone metastases. However, bisphosphonates can have side effects such as osteonecrosis of the jaw (ONJ), atypical femoral fractures, and kidney damage.\nDenosumab, on the other hand, works by targeting a protein called RANK ligand, which is involved in the formation and activity of osteoclasts. Denosumab can also help reduce the risk of fractures and pain associated with bone metastases, but it may have a lower risk of ONJ and atypical femoral fractures compared to bisphosphonates. However, denosumab can have side effects such as hypocalcemia (low calcium levels) and an increased risk of infections.\nThere have been some studies comparing bisphosphonates and denosumab in the treatment of bone metastases in men with prostate cancer. A 2019 systematic review and meta-analysis published in the journal European Urology found that both bisphosphonates and denosumab were effective in reducing the risk of skeletal-related events (SREs) such as fractures and spinal cord compression, but denosumab may have a slight advantage in terms of reducing the risk of SREs and improving pain. However, the review also noted that the quality of the evidence was generally low and that further research was needed to determine the optimal treatment strategy.\nIn summary, both bisphosphonates and denosumab can be effective in treating bone metastases in men with prostate cancer, but they have different side effect profiles and may have different efficacy. The choice between the two should be individualized and discussed with a healthcare provider, taking into account the patient's medical history, current health status, and personal preferences",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For men with prostate cancer and bone metastases, how do bisphosphonates compare with each other and with denosumab?[/INST]",
            "topic1": [
                "cancers"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Mocellin, Simone"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 97,
                            "score": 0.5,
                            "text": "Bisphosphonates and denosumab are both used to treat bone metastases in men with prostate cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 98,
                            "end": 152,
                            "score": 0.5,
                            "text": "They work differently and have different side effects.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 153,
                            "end": 301,
                            "score": 0.5,
                            "text": "Bisphosphonates, such as zoledronic acid and pamidronate, work by inhibiting the activity of cells called osteoclasts, which break down bone tissue.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 302,
                            "end": 386,
                            "score": 0.5,
                            "text": "This can help reduce the risk of fractures and pain associated with bone metastases.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 387,
                            "end": 520,
                            "score": 0.5,
                            "text": "However, bisphosphonates can have side effects such as osteonecrosis of the jaw (ONJ), atypical femoral fractures, and kidney damage.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 521,
                            "end": 663,
                            "score": 0.5,
                            "text": "Denosumab, on the other hand, works by targeting a protein called RANK ligand, which is involved in the formation and activity of osteoclasts.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 664,
                            "end": 854,
                            "score": 0.5,
                            "text": "Denosumab can also help reduce the risk of fractures and pain associated with bone metastases, but it may have a lower risk of ONJ and atypical femoral fractures compared to bisphosphonates.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 855,
                            "end": 974,
                            "score": 0.5,
                            "text": "However, denosumab can have side effects such as hypocalcemia (low calcium levels) and an increased risk of infections.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 975,
                            "end": 1108,
                            "score": 0.5,
                            "text": "There have been some studies comparing bisphosphonates and denosumab in the treatment of bone metastases in men with prostate cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1109,
                            "end": 1456,
                            "score": 0.5,
                            "text": "A 2019 systematic review and meta-analysis published in the journal European Urology found that both bisphosphonates and denosumab were effective in reducing the risk of skeletal-related events (SREs) such as fractures and spinal cord compression, but denosumab may have a slight advantage in terms of reducing the risk of SREs and improving pain.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1457,
                            "end": 1620,
                            "score": 0.5,
                            "text": "However, the review also noted that the quality of the evidence was generally low and that further research was needed to determine the optimal treatment strategy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1621,
                            "end": 1819,
                            "score": 0.5,
                            "text": "In summary, both bisphosphonates and denosumab can be effective in treating bone metastases in men with prostate cancer, but they have different side effect profiles and may have different efficacy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3555_llama2_70b_chat_prompt1_answer_sent12",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1820,
                            "end": 2012,
                            "score": 0.5,
                            "text": "The choice between the two should be individualized and discussed with a healthcare provider, taking into account the patient's medical history, current health status, and personal preferences",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4290",
            "question": "What are the effects of lifestyle interventions for weight reduction in women with endometrial cancer?",
            "gold_answer": "Researchers conducted a search in June 2022 and identified only low\u2010 to very low\u2010certainty evidence suggesting little to no difference between lifestyle intervention and usual care in women with endometrial cancer and overweight or obesity. Consequently, no inferences can be made regarding the effects of lifestyle interventions for weight reduction in this population.",
            "gold_answer_terms": "CANCER (cancer): A disease of the cells.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4290",
            "llm_answer": "Lifestyle interventions, including diet and exercise, have been shown to be effective in reducing weight and improving outcomes in women with endometrial cancer. Studies have found that weight loss through lifestyle changes can lead to improvements in tumor markers, reduced risk of recurrence, and improved overall survival. Additionally, lifestyle interventions can also improve quality of life, reduce symptoms, and enhance psychological well-being in women with endometrial cancer.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> What are the effects of lifestyle interventions for weight reduction in women with endometrial cancer?[/INST]",
            "topic1": [
                "cancers",
                "endocrine metabolic"
            ],
            "topic2": [
                "obesity"
            ],
            "year": 2023,
            "author": "Tort, Sera; Ciapponi, Agust\u00edn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 161,
                            "score": 0.5,
                            "text": "Lifestyle interventions, including diet and exercise, have been shown to be effective in reducing weight and improving outcomes in women with endometrial cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 162,
                            "end": 325,
                            "score": 0.5,
                            "text": "Studies have found that weight loss through lifestyle changes can lead to improvements in tumor markers, reduced risk of recurrence, and improved overall survival.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 326,
                            "end": 485,
                            "score": 0.5,
                            "text": "Additionally, lifestyle interventions can also improve quality of life, reduce symptoms, and enhance psychological well-being in women with endometrial cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4290",
            "question": "What are the effects of lifestyle interventions for weight reduction in women with endometrial cancer?",
            "gold_answer": "Researchers conducted a search in June 2022 and identified only low\u2010 to very low\u2010certainty evidence suggesting little to no difference between lifestyle intervention and usual care in women with endometrial cancer and overweight or obesity. Consequently, no inferences can be made regarding the effects of lifestyle interventions for weight reduction in this population.",
            "gold_answer_terms": "CANCER (cancer): A disease of the cells.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4290",
            "llm_answer": "Lifestyle interventions, such as diet and exercise, have been shown to have a positive impact on weight reduction in women with endometrial cancer. Studies have found that these interventions can lead to significant weight loss, improved body composition, and reduced risk factors for cancer recurrence. Additionally, lifestyle interventions can also improve overall health and quality of life in women with endometrial cancer.\nIt's important to note that the most effective lifestyle interventions for weight reduction in women with endometrial cancer are those that are tailored to the individual's specific needs and goals, and that are delivered by a healthcare professional or registered dietitian. It's also important to note that weight loss should not be the only goal, but also the maintenance of a healthy weight and lifestyle habits.\nIt's also important to note that lifestyle interventions may not be appropriate or effective for all women with endometrial cancer, and that the decision to initiate a lifestyle intervention should be made on a case-by-case basis, taking into account the individual's overall health, medical history, and treatment plan.\nIt's important to consult a healthcare professional before starting any lifestyle intervention, especially if you have a history of endometrial cancer. They can help you determine the best course of action for your specific needs and health status.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> What are the effects of lifestyle interventions for weight reduction in women with endometrial cancer?[/INST]",
            "topic1": [
                "cancers",
                "endocrine metabolic"
            ],
            "topic2": [
                "obesity"
            ],
            "year": 2023,
            "author": "Tort, Sera; Ciapponi, Agust\u00edn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 147,
                            "score": 0.5,
                            "text": "Lifestyle interventions, such as diet and exercise, have been shown to have a positive impact on weight reduction in women with endometrial cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 148,
                            "end": 303,
                            "score": 0.5,
                            "text": "Studies have found that these interventions can lead to significant weight loss, improved body composition, and reduced risk factors for cancer recurrence.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 304,
                            "end": 427,
                            "score": 0.5,
                            "text": "Additionally, lifestyle interventions can also improve overall health and quality of life in women with endometrial cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 428,
                            "end": 703,
                            "score": 0.5,
                            "text": "It's important to note that the most effective lifestyle interventions for weight reduction in women with endometrial cancer are those that are tailored to the individual's specific needs and goals, and that are delivered by a healthcare professional or registered dietitian.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 704,
                            "end": 844,
                            "score": 0.5,
                            "text": "It's also important to note that weight loss should not be the only goal, but also the maintenance of a healthy weight and lifestyle habits.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 845,
                            "end": 1165,
                            "score": 0.5,
                            "text": "It's also important to note that lifestyle interventions may not be appropriate or effective for all women with endometrial cancer, and that the decision to initiate a lifestyle intervention should be made on a case-by-case basis, taking into account the individual's overall health, medical history, and treatment plan.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1166,
                            "end": 1317,
                            "score": 0.5,
                            "text": "It's important to consult a healthcare professional before starting any lifestyle intervention, especially if you have a history of endometrial cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4290_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1318,
                            "end": 1414,
                            "score": 0.5,
                            "text": "They can help you determine the best course of action for your specific needs and health status.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4044",
            "question": "For women receiving endocrine therapy for the treatment of early\u2010stage breast cancer, can breast density reduction predict outcomes?",
            "gold_answer": "For women receiving endocrine therapy for the treatment of early\u2010stage breast cancer, low\u2010certainty evidence suggests that there may be a decrease in breast cancer mortality associated with mammographic density reduction (as a result of endocrine therapy). Results for other outcomes (recurrence or incidence of a secondary primary breast cancer) were very uncertain. No information was available on important outcomes (disease\u2010free survival, all\u2010cause mortality, recurrence of invasive cancer only or carcinoma ductal in situ (DCIS) cancer only, adverse events).",
            "gold_answer_terms": "CANCER (cancer): A disease of the cells.\nMORTALITY (mortality): death\nINVASIVE (invasive): A medical procedure when a cut is made to the body or an instrument is inserted.\nCARCINOMA (carcinoma): type of cancer",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4044",
            "llm_answer": "Yes, breast density reduction can predict outcomes for women receiving endocrine therapy for early-stage breast cancer. Studies have shown that a reduction in breast density during endocrine therapy is associated with improved clinical outcomes, including reduced risk of breast cancer recurrence and improved overall survival.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For women receiving endocrine therapy for the treatment of early\u2010stage breast cancer, can breast density reduction predict outcomes?[/INST]",
            "topic1": [
                "cancers"
            ],
            "topic2": [
                "breast cancer"
            ],
            "year": 2023,
            "author": "Tort, Sera; Poulakaki, Fiorita"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4044_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4044_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 119,
                            "score": 0.5,
                            "text": "Yes, breast density reduction can predict outcomes for women receiving endocrine therapy for early-stage breast cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4044_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 120,
                            "end": 327,
                            "score": 0.5,
                            "text": "Studies have shown that a reduction in breast density during endocrine therapy is associated with improved clinical outcomes, including reduced risk of breast cancer recurrence and improved overall survival.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4044",
            "question": "For women receiving endocrine therapy for the treatment of early\u2010stage breast cancer, can breast density reduction predict outcomes?",
            "gold_answer": "For women receiving endocrine therapy for the treatment of early\u2010stage breast cancer, low\u2010certainty evidence suggests that there may be a decrease in breast cancer mortality associated with mammographic density reduction (as a result of endocrine therapy). Results for other outcomes (recurrence or incidence of a secondary primary breast cancer) were very uncertain. No information was available on important outcomes (disease\u2010free survival, all\u2010cause mortality, recurrence of invasive cancer only or carcinoma ductal in situ (DCIS) cancer only, adverse events).",
            "gold_answer_terms": "CANCER (cancer): A disease of the cells.\nMORTALITY (mortality): death\nINVASIVE (invasive): A medical procedure when a cut is made to the body or an instrument is inserted.\nCARCINOMA (carcinoma): type of cancer",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4044",
            "llm_answer": "Yes, breast density reduction can be a predictor of outcomes for women receiving endocrine therapy for early-stage breast cancer. Studies have shown that women who experience a greater reduction in breast density during endocrine therapy tend to have a lower risk of recurrence and improved overall survival compared to those with less reduction in breast density. However, it's important to note that breast density is just one factor that can influence treatment outcomes, and other factors such as tumor size, nodal involvement, and hormone receptor status also play a role. It's important for women to discuss their individual risk factors and treatment options with their healthcare provider to determine the best course of action for their specific situation.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For women receiving endocrine therapy for the treatment of early\u2010stage breast cancer, can breast density reduction predict outcomes?[/INST]",
            "topic1": [
                "cancers"
            ],
            "topic2": [
                "breast cancer"
            ],
            "year": 2023,
            "author": "Tort, Sera; Poulakaki, Fiorita"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4044_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4044_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 129,
                            "score": 0.5,
                            "text": "Yes, breast density reduction can be a predictor of outcomes for women receiving endocrine therapy for early-stage breast cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4044_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 130,
                            "end": 364,
                            "score": 0.5,
                            "text": "Studies have shown that women who experience a greater reduction in breast density during endocrine therapy tend to have a lower risk of recurrence and improved overall survival compared to those with less reduction in breast density.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4044_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 365,
                            "end": 577,
                            "score": 0.5,
                            "text": "However, it's important to note that breast density is just one factor that can influence treatment outcomes, and other factors such as tumor size, nodal involvement, and hormone receptor status also play a role.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4044_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 578,
                            "end": 765,
                            "score": 0.5,
                            "text": "It's important for women to discuss their individual risk factors and treatment options with their healthcare provider to determine the best course of action for their specific situation.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3781",
            "question": "For older adults admitted to general (non\u2010intensive care unit [ICU]) hospital settings, what are the effects of multi\u2010component delirium prevention interventions?",
            "gold_answer": "Compared with usual care for older adults admitted to non\u2010ICU hospital settings, moderate\u2010certainty evidence shows that multi\u2010component delirium prevention interventions probably reduce the number of people experiencing delirium (81 vs 143 per 1000 people; all results on average). When reviewers analyzed individual components, they noted apparent benefit for three in terms of reducing delirium (reorientation and familiar objects; cognitive stimulation; sleep hygiene). Low\u2010certainty evidence suggests multi\u2010component delirium prevention interventions may reduce duration of hospital stay (by 1.3 days) and the number of people newly admitted to a care home on discharge (190 vs 247 per 1000 people). Results for mortality, duration of delirium episodes, re\u2010admissions to hospital, and falls were uncertain.",
            "gold_answer_terms": "TERM (term): Between 37 and 42 weeks of pregnancy.\nMORTALITY (mortality): death",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3781",
            "llm_answer": "Multi-component delirium prevention interventions in older adults admitted to general hospital settings have been shown to reduce the incidence of delirium, duration of delirium, and length of hospital stay. These interventions typically include a combination of non-pharmacological interventions such as cognitive stimulation, sleep promotion, sensory stimulation, and mobility promotion, as well as medication management and staff education. The effects of these interventions have been shown to be most effective when started early in the hospital stay and tailored to the individual patient's needs.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For older adults admitted to general (non\u2010intensive care unit [ICU]) hospital settings, what are the effects of multi\u2010component delirium prevention interventions?[/INST]",
            "topic1": [
                "mental health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Venin\u0161ek, Gregor"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 207,
                            "score": 0.5,
                            "text": "Multi-component delirium prevention interventions in older adults admitted to general hospital settings have been shown to reduce the incidence of delirium, duration of delirium, and length of hospital stay.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 208,
                            "end": 443,
                            "score": 0.5,
                            "text": "These interventions typically include a combination of non-pharmacological interventions such as cognitive stimulation, sleep promotion, sensory stimulation, and mobility promotion, as well as medication management and staff education.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 444,
                            "end": 603,
                            "score": 0.5,
                            "text": "The effects of these interventions have been shown to be most effective when started early in the hospital stay and tailored to the individual patient's needs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3781",
            "question": "For older adults admitted to general (non\u2010intensive care unit [ICU]) hospital settings, what are the effects of multi\u2010component delirium prevention interventions?",
            "gold_answer": "Compared with usual care for older adults admitted to non\u2010ICU hospital settings, moderate\u2010certainty evidence shows that multi\u2010component delirium prevention interventions probably reduce the number of people experiencing delirium (81 vs 143 per 1000 people; all results on average). When reviewers analyzed individual components, they noted apparent benefit for three in terms of reducing delirium (reorientation and familiar objects; cognitive stimulation; sleep hygiene). Low\u2010certainty evidence suggests multi\u2010component delirium prevention interventions may reduce duration of hospital stay (by 1.3 days) and the number of people newly admitted to a care home on discharge (190 vs 247 per 1000 people). Results for mortality, duration of delirium episodes, re\u2010admissions to hospital, and falls were uncertain.",
            "gold_answer_terms": "TERM (term): Between 37 and 42 weeks of pregnancy.\nMORTALITY (mortality): death",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3781",
            "llm_answer": "Multi-component delirium prevention interventions have been shown to be effective in reducing the incidence and severity of delirium in older adults admitted to general hospital settings. These interventions typically include a combination of non-pharmacological and pharmacological strategies, such as:\n* Reorientation and reassurance\n* Sensory stimulation and cognitive stimulation\n* Mobilization and rehabilitation\n* Sleep promotion\n* Pain management\n* Medication review and optimization\nStudies have consistently shown that these interventions can lead to a significant reduction in delirium incidence, duration, and severity, as well as a decrease in hospital length of stay, falls, and mortality. Additionally, these interventions have been found to be cost-effective and improve patient and family satisfaction.\nIt is important to note that the effectiveness of these interventions can vary depending on the individual patient and the specific interventions used, and it is crucial to tailor the interventions to the individual patient's needs and circumstances. It is also important to ensure that the interventions are implemented correctly and consistently, and that they are combined with ongoing monitoring and evaluation of the patient's condition.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For older adults admitted to general (non\u2010intensive care unit [ICU]) hospital settings, what are the effects of multi\u2010component delirium prevention interventions?[/INST]",
            "topic1": [
                "mental health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Venin\u0161ek, Gregor"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 187,
                            "score": 0.5,
                            "text": "Multi-component delirium prevention interventions have been shown to be effective in reducing the incidence and severity of delirium in older adults admitted to general hospital settings.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 188,
                            "end": 303,
                            "score": 0.5,
                            "text": "These interventions typically include a combination of non-pharmacological and pharmacological strategies, such as:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 304,
                            "end": 335,
                            "score": 0.5,
                            "text": "* Reorientation and reassurance",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 336,
                            "end": 383,
                            "score": 0.5,
                            "text": "* Sensory stimulation and cognitive stimulation",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 384,
                            "end": 417,
                            "score": 0.5,
                            "text": "* Mobilization and rehabilitation",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 418,
                            "end": 435,
                            "score": 0.5,
                            "text": "* Sleep promotion",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 436,
                            "end": 453,
                            "score": 0.5,
                            "text": "* Pain management",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 454,
                            "end": 490,
                            "score": 0.5,
                            "text": "* Medication review and optimization",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 491,
                            "end": 702,
                            "score": 0.5,
                            "text": "Studies have consistently shown that these interventions can lead to a significant reduction in delirium incidence, duration, and severity, as well as a decrease in hospital length of stay, falls, and mortality.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 703,
                            "end": 818,
                            "score": 0.5,
                            "text": "Additionally, these interventions have been found to be cost-effective and improve patient and family satisfaction.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 819,
                            "end": 1069,
                            "score": 0.5,
                            "text": "It is important to note that the effectiveness of these interventions can vary depending on the individual patient and the specific interventions used, and it is crucial to tailor the interventions to the individual patient's needs and circumstances.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3781_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1070,
                            "end": 1261,
                            "score": 0.5,
                            "text": "It is also important to ensure that the interventions are implemented correctly and consistently, and that they are combined with ongoing monitoring and evaluation of the patient's condition.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4101",
            "question": "How does pulmonary rehabilitation compare with usual care for adults with asthma?",
            "gold_answer": "For adults with mild to severe asthma, moderate\u2010certainty evidence shows that compared with usual care, pulmonary rehabilitation assessed at the end of the program probably results in moderate improvements in functional exercise capacity (80 more meters on the 6\u2010minute walk test; all results on average) and quality of life. Low\u2010certainty evidence suggests that pulmonary rehabilitation may also result in a 15% higher predicted maximal oxygen uptake and slightly better asthma control at the end of the program, but the evidence is very uncertain regarding peak oxygen uptake. At longer follow\u2010ups there may be minimal to no important difference in asthma control (low\u2010certainty evidence); however, the evidence for the other outcomes at longer follow\u2010ups is very uncertain.",
            "gold_answer_terms": "ASTHMA (asthma): lung disease associated with tightening of air passages, making breathing difficult\nPULMONARY (pulmonary): pertaining to the lungs\nASSESS (assess): to learn about, measure, evaluate, look at\nTESTES (testes): male sex glands\nUPTAKE (uptake): absorbing and taking in of a substance by living tissue\nMINIMAL (minimal): slight\nMINIMIZE (minimize): reduce as much as possible Page 4 of 7",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4101",
            "llm_answer": "Pulmonary rehabilitation has been shown to be more effective than usual care for adults with asthma in improving lung function, reducing symptoms, and improving quality of life. Pulmonary rehabilitation includes exercise training, education, and behavior modification, which can help patients better manage their asthma and improve their overall health. In contrast, usual care for asthma typically focuses on medication management and may not address the comprehensive needs of patients. Studies have consistently shown that pulmonary rehabilitation can lead to significant improvements in asthma control, lung function, and quality of life compared to usual care.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How does pulmonary rehabilitation compare with usual care for adults with asthma?[/INST]",
            "topic1": [
                "lungs airways"
            ],
            "topic2": [
                "asthma chronic"
            ],
            "year": 2022,
            "author": "Ciapponi, Agust\u00edn; Gupta, Adarsh"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 177,
                            "score": 0.5,
                            "text": "Pulmonary rehabilitation has been shown to be more effective than usual care for adults with asthma in improving lung function, reducing symptoms, and improving quality of life.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 178,
                            "end": 353,
                            "score": 0.5,
                            "text": "Pulmonary rehabilitation includes exercise training, education, and behavior modification, which can help patients better manage their asthma and improve their overall health.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 354,
                            "end": 488,
                            "score": 0.5,
                            "text": "In contrast, usual care for asthma typically focuses on medication management and may not address the comprehensive needs of patients.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 489,
                            "end": 665,
                            "score": 0.5,
                            "text": "Studies have consistently shown that pulmonary rehabilitation can lead to significant improvements in asthma control, lung function, and quality of life compared to usual care.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4101",
            "question": "How does pulmonary rehabilitation compare with usual care for adults with asthma?",
            "gold_answer": "For adults with mild to severe asthma, moderate\u2010certainty evidence shows that compared with usual care, pulmonary rehabilitation assessed at the end of the program probably results in moderate improvements in functional exercise capacity (80 more meters on the 6\u2010minute walk test; all results on average) and quality of life. Low\u2010certainty evidence suggests that pulmonary rehabilitation may also result in a 15% higher predicted maximal oxygen uptake and slightly better asthma control at the end of the program, but the evidence is very uncertain regarding peak oxygen uptake. At longer follow\u2010ups there may be minimal to no important difference in asthma control (low\u2010certainty evidence); however, the evidence for the other outcomes at longer follow\u2010ups is very uncertain.",
            "gold_answer_terms": "ASTHMA (asthma): lung disease associated with tightening of air passages, making breathing difficult\nPULMONARY (pulmonary): pertaining to the lungs\nASSESS (assess): to learn about, measure, evaluate, look at\nTESTES (testes): male sex glands\nUPTAKE (uptake): absorbing and taking in of a substance by living tissue\nMINIMAL (minimal): slight\nMINIMIZE (minimize): reduce as much as possible Page 4 of 7",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4101",
            "llm_answer": "Pulmonary rehabilitation (PR) is a comprehensive intervention that includes exercise training, education, and behavior modification, designed to improve the physical and emotional well-being of individuals with chronic respiratory diseases, such as asthma. When compared to usual care for adults with asthma, PR has been shown to have several benefits.\nFirstly, PR can improve lung function and exercise tolerance. Studies have consistently shown that PR can increase forced expiratory volume in one second (FEV1) and six-minute walking distance (6MWD) in individuals with asthma.\nSecondly, PR can reduce symptoms and improve quality of life. PR has been shown to decrease the frequency and severity of asthma symptoms, such as shortness of breath and wheezing, and improve overall quality of life, as measured by standardized questionnaires.\nThirdly, PR can reduce healthcare utilization. By improving lung function and symptoms, PR can reduce the need for hospitalizations, emergency department visits, and medication use.\nLastly, PR can improve comorbidities. Asthma is often associated with other health conditions, such as anxiety, depression, and cardiovascular disease. PR has been shown to improve these comorbidities, leading to better overall health outcomes.\nIn summary, pulmonary rehabilitation has been shown to be an effective intervention for adults with asthma, improving lung function, symptoms, quality of life, healthcare utilization, and comorbidities, when compared to usual care. It is a safe and effective way to manage asthma and improve overall health outcomes.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How does pulmonary rehabilitation compare with usual care for adults with asthma?[/INST]",
            "topic1": [
                "lungs airways"
            ],
            "topic2": [
                "asthma chronic"
            ],
            "year": 2022,
            "author": "Ciapponi, Agust\u00edn; Gupta, Adarsh"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 256,
                            "score": 0.5,
                            "text": "Pulmonary rehabilitation (PR) is a comprehensive intervention that includes exercise training, education, and behavior modification, designed to improve the physical and emotional well-being of individuals with chronic respiratory diseases, such as asthma.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 257,
                            "end": 352,
                            "score": 0.5,
                            "text": "When compared to usual care for adults with asthma, PR has been shown to have several benefits.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 353,
                            "end": 414,
                            "score": 0.5,
                            "text": "Firstly, PR can improve lung function and exercise tolerance.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 415,
                            "end": 580,
                            "score": 0.5,
                            "text": "Studies have consistently shown that PR can increase forced expiratory volume in one second (FEV1) and six-minute walking distance (6MWD) in individuals with asthma.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 581,
                            "end": 642,
                            "score": 0.5,
                            "text": "Secondly, PR can reduce symptoms and improve quality of life.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 643,
                            "end": 842,
                            "score": 0.5,
                            "text": "PR has been shown to decrease the frequency and severity of asthma symptoms, such as shortness of breath and wheezing, and improve overall quality of life, as measured by standardized questionnaires.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 843,
                            "end": 889,
                            "score": 0.5,
                            "text": "Thirdly, PR can reduce healthcare utilization.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 890,
                            "end": 1024,
                            "score": 0.5,
                            "text": "By improving lung function and symptoms, PR can reduce the need for hospitalizations, emergency department visits, and medication use.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1025,
                            "end": 1062,
                            "score": 0.5,
                            "text": "Lastly, PR can improve comorbidities.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1063,
                            "end": 1176,
                            "score": 0.5,
                            "text": "Asthma is often associated with other health conditions, such as anxiety, depression, and cardiovascular disease.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1177,
                            "end": 1269,
                            "score": 0.5,
                            "text": "PR has been shown to improve these comorbidities, leading to better overall health outcomes.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1270,
                            "end": 1501,
                            "score": 0.5,
                            "text": "In summary, pulmonary rehabilitation has been shown to be an effective intervention for adults with asthma, improving lung function, symptoms, quality of life, healthcare utilization, and comorbidities, when compared to usual care.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4101_llama2_70b_chat_prompt1_answer_sent12",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1502,
                            "end": 1586,
                            "score": 0.5,
                            "text": "It is a safe and effective way to manage asthma and improve overall health outcomes.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3914",
            "question": "For adults with hypertension, how do calcium channel blockers (CCBs) compare with other drug classes in reducing major adverse cardiovascular events?",
            "gold_answer": "While there were no clear differences in mortality rates in all the comparisons between CCBs and other drug agents, diuretics may be more effective at reducing congestive heart failure (CHF) and major cardiovascular events (MACE) than CCBs. Compared with beta blockers, CCBs may reduce cardiovascular mortality, stroke, and MACE. Compared with angiotensin receptor (ACE) inhibitors, CCBs may reduce the risk of stroke. Compared with angiotensin receptor blockers (ARBs), CCBs may reduce myocardial infarction (MI). Compared with ACE inhibitors or ARBs, CCBs may increase the risk of CHF. Given the variability among drug classes, agent selection should be predicated on patient\u2010specific complication risks. Moderate\u2010 to low\u2010certainty evidence suggests that there may be little to no difference between CCBs and other drug classes in all\u2010cause mortality. Moderate\u2010certainty evidence shows that when compared with diuretics, CCBs probably result in little to no difference in cardiovascular mortality, MI, or stroke, but may potentially lead to a higher risk of CHF (78 vs 57 per 1000 people; all results on average) and MACE (270 vs 258 per 1000 people; based on 33,643 people) at two to five years follow\u2010up. Low\u2010certainty evidence suggests that when compared with beta blockers, CCBs may result in a small reduction in cardiovascular mortality risk (34 vs 38 per 1000 people). Moderate\u2010certainty evidence shows that CCBs probably result in lower risk of stroke (34 vs 44 per 1000 people) and MACE (82 vs 97 per 1000 people; based on 22,249 people), with little to no difference in risk of MI or CHF at three to five years follow\u2010up. Moderate\u2010certainty evidence shows that when compared with ACE inhibitors, CCBs probably result in little to no difference in cardiovascular mortality at three to five years follow\u2010up. Low\u2010certainty evidence suggests that in people receiving CCBs, there may be little to no difference in risk of MI or MACE (based on 25,186 people). Low\u2010certainty evidence also suggests that in people receiving CCBs, there may be reduced risk of stroke (45 vs 50 per 1000 people) and an increased risk of CHF (79 vs 68 per 1000 people). Moderate\u2010certainty evidence shows that when compared with ARBs, CCBs probably result in little to no difference in cardiovascular mortality at two to six years follow\u2010up. In people receiving CCBs, low\u2010certainty evidence suggests that there may be a reduced risk of MI (40 vs 48 per 1000 people), but an increased risk of CHF (56 vs 46 per 1000 people), with little to no difference in risk of MACE (based on 6874 people). The reviewers found no RCTs comparing CCBs with alpha\u20101 antagonists.",
            "gold_answer_terms": "MORTALITY (mortality): death\nDIURETIC (diuretic): \"water pill\" or drug that causes increase in urination\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nMYOCARDIAL (myocardial): pertaining to the heart muscle\nINFARCT (infarct): death of tissue due to lack of blood supply\nMI (mi): myocardial infarction, heart attack\nCOMPLICATIONS (complications): Problems that develop after an operation, treatment or illness.\nPOTENTIAL (potential): possible\nPOTENTIATE (potentiate): increase or multiply the effect of a drug or toxin (poison) by giving another drug or toxin at the same time (sometimes an unintentional result)\nPOTENTIATOR (potentiator): an agent that helps another agent work better\nRCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3914",
            "llm_answer": "Calcium channel blockers (CCBs) are effective in reducing major adverse cardiovascular events in adults with hypertension, but their efficacy varies compared to other drug classes.\nCCBs have been shown to reduce the risk of stroke, heart attack, and heart failure compared to placebo or no treatment. However, they may not be as effective as other drug classes, such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), in reducing cardiovascular events, especially in patients with diabetes or renal disease.\nOne meta-analysis of 24 randomized controlled trials found that CCBs reduced the risk of cardiovascular events by 14% compared to placebo, but ACE inhibitors and ARBs reduced the risk by 21% and 18%, respectively.\nHowever, CCBs may have a more favorable risk-benefit profile than other drug classes in certain patient populations, such as those with heart failure or peripheral artery disease. Additionally, CCBs may have a more tolerable side effect profile than other medications, such as beta-blockers, which can cause fatigue, slowed heart rate, and sexual dysfunction.\nIn summary, while CCBs are effective in reducing major adverse cardiovascular events in adults with hypertension, their efficacy may vary compared to other drug classes, and the choice of medication should be individualized based on patient-specific factors and comorbidities.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For adults with hypertension, how do calcium channel blockers (CCBs) compare with other drug classes in reducing major adverse cardiovascular events?[/INST]",
            "topic1": [
                "kidney disease",
                "heart circulation"
            ],
            "topic2": [
                "hypertension"
            ],
            "year": 2022,
            "author": "Gruenebaum, Dane"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 180,
                            "score": 0.5,
                            "text": "Calcium channel blockers (CCBs) are effective in reducing major adverse cardiovascular events in adults with hypertension, but their efficacy varies compared to other drug classes.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 181,
                            "end": 300,
                            "score": 0.5,
                            "text": "CCBs have been shown to reduce the risk of stroke, heart attack, and heart failure compared to placebo or no treatment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 301,
                            "end": 547,
                            "score": 0.5,
                            "text": "However, they may not be as effective as other drug classes, such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), in reducing cardiovascular events, especially in patients with diabetes or renal disease.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 548,
                            "end": 761,
                            "score": 0.5,
                            "text": "One meta-analysis of 24 randomized controlled trials found that CCBs reduced the risk of cardiovascular events by 14% compared to placebo, but ACE inhibitors and ARBs reduced the risk by 21% and 18%, respectively.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 762,
                            "end": 941,
                            "score": 0.5,
                            "text": "However, CCBs may have a more favorable risk-benefit profile than other drug classes in certain patient populations, such as those with heart failure or peripheral artery disease.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt0_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 942,
                            "end": 1121,
                            "score": 0.5,
                            "text": "Additionally, CCBs may have a more tolerable side effect profile than other medications, such as beta-blockers, which can cause fatigue, slowed heart rate, and sexual dysfunction.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt0_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1122,
                            "end": 1398,
                            "score": 0.5,
                            "text": "In summary, while CCBs are effective in reducing major adverse cardiovascular events in adults with hypertension, their efficacy may vary compared to other drug classes, and the choice of medication should be individualized based on patient-specific factors and comorbidities.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3914",
            "question": "For adults with hypertension, how do calcium channel blockers (CCBs) compare with other drug classes in reducing major adverse cardiovascular events?",
            "gold_answer": "While there were no clear differences in mortality rates in all the comparisons between CCBs and other drug agents, diuretics may be more effective at reducing congestive heart failure (CHF) and major cardiovascular events (MACE) than CCBs. Compared with beta blockers, CCBs may reduce cardiovascular mortality, stroke, and MACE. Compared with angiotensin receptor (ACE) inhibitors, CCBs may reduce the risk of stroke. Compared with angiotensin receptor blockers (ARBs), CCBs may reduce myocardial infarction (MI). Compared with ACE inhibitors or ARBs, CCBs may increase the risk of CHF. Given the variability among drug classes, agent selection should be predicated on patient\u2010specific complication risks. Moderate\u2010 to low\u2010certainty evidence suggests that there may be little to no difference between CCBs and other drug classes in all\u2010cause mortality. Moderate\u2010certainty evidence shows that when compared with diuretics, CCBs probably result in little to no difference in cardiovascular mortality, MI, or stroke, but may potentially lead to a higher risk of CHF (78 vs 57 per 1000 people; all results on average) and MACE (270 vs 258 per 1000 people; based on 33,643 people) at two to five years follow\u2010up. Low\u2010certainty evidence suggests that when compared with beta blockers, CCBs may result in a small reduction in cardiovascular mortality risk (34 vs 38 per 1000 people). Moderate\u2010certainty evidence shows that CCBs probably result in lower risk of stroke (34 vs 44 per 1000 people) and MACE (82 vs 97 per 1000 people; based on 22,249 people), with little to no difference in risk of MI or CHF at three to five years follow\u2010up. Moderate\u2010certainty evidence shows that when compared with ACE inhibitors, CCBs probably result in little to no difference in cardiovascular mortality at three to five years follow\u2010up. Low\u2010certainty evidence suggests that in people receiving CCBs, there may be little to no difference in risk of MI or MACE (based on 25,186 people). Low\u2010certainty evidence also suggests that in people receiving CCBs, there may be reduced risk of stroke (45 vs 50 per 1000 people) and an increased risk of CHF (79 vs 68 per 1000 people). Moderate\u2010certainty evidence shows that when compared with ARBs, CCBs probably result in little to no difference in cardiovascular mortality at two to six years follow\u2010up. In people receiving CCBs, low\u2010certainty evidence suggests that there may be a reduced risk of MI (40 vs 48 per 1000 people), but an increased risk of CHF (56 vs 46 per 1000 people), with little to no difference in risk of MACE (based on 6874 people). The reviewers found no RCTs comparing CCBs with alpha\u20101 antagonists.",
            "gold_answer_terms": "MORTALITY (mortality): death\nDIURETIC (diuretic): \"water pill\" or drug that causes increase in urination\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nMYOCARDIAL (myocardial): pertaining to the heart muscle\nINFARCT (infarct): death of tissue due to lack of blood supply\nMI (mi): myocardial infarction, heart attack\nCOMPLICATIONS (complications): Problems that develop after an operation, treatment or illness.\nPOTENTIAL (potential): possible\nPOTENTIATE (potentiate): increase or multiply the effect of a drug or toxin (poison) by giving another drug or toxin at the same time (sometimes an unintentional result)\nPOTENTIATOR (potentiator): an agent that helps another agent work better\nRCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3914",
            "llm_answer": "Calcium channel blockers (CCBs) are a class of medications commonly used to treat hypertension (high blood pressure). In comparison to other drug classes, CCBs have been shown to be effective in reducing major adverse cardiovascular events, such as heart attacks, strokes, and heart failure.\nOne study published in the Journal of the American College of Cardiology found that CCBs were associated with a lower risk of cardiovascular events compared to other antihypertensive medications, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and diuretics.\nAnother study published in the European Journal of Clinical Pharmacology found that CCBs were associated with a lower risk of cardiovascular events and all-cause mortality compared to beta-blockers.\nHowever, it's important to note that the choice of medication and drug class depends on various factors, including the individual patient's medical history, comorbidities, and response to medications. Your healthcare provider will be able to determine the most appropriate treatment plan for you based on your specific needs and medical history.\nIt's important to note that CCBs may have different effects on different people, and it's important to consult a doctor before taking any medication. Additionally, it's important to maintain a healthy lifestyle, including a balanced diet, regular exercise, and stress management, to help control hypertension and reduce the risk of cardiovascular events.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For adults with hypertension, how do calcium channel blockers (CCBs) compare with other drug classes in reducing major adverse cardiovascular events?[/INST]",
            "topic1": [
                "kidney disease",
                "heart circulation"
            ],
            "topic2": [
                "hypertension"
            ],
            "year": 2022,
            "author": "Gruenebaum, Dane"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 117,
                            "score": 0.5,
                            "text": "Calcium channel blockers (CCBs) are a class of medications commonly used to treat hypertension (high blood pressure).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 118,
                            "end": 291,
                            "score": 0.5,
                            "text": "In comparison to other drug classes, CCBs have been shown to be effective in reducing major adverse cardiovascular events, such as heart attacks, strokes, and heart failure.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 292,
                            "end": 598,
                            "score": 0.5,
                            "text": "One study published in the Journal of the American College of Cardiology found that CCBs were associated with a lower risk of cardiovascular events compared to other antihypertensive medications, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and diuretics.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 599,
                            "end": 797,
                            "score": 0.5,
                            "text": "Another study published in the European Journal of Clinical Pharmacology found that CCBs were associated with a lower risk of cardiovascular events and all-cause mortality compared to beta-blockers.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 798,
                            "end": 998,
                            "score": 0.5,
                            "text": "However, it's important to note that the choice of medication and drug class depends on various factors, including the individual patient's medical history, comorbidities, and response to medications.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 999,
                            "end": 1143,
                            "score": 0.5,
                            "text": "Your healthcare provider will be able to determine the most appropriate treatment plan for you based on your specific needs and medical history.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1144,
                            "end": 1293,
                            "score": 0.5,
                            "text": "It's important to note that CCBs may have different effects on different people, and it's important to consult a doctor before taking any medication.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3914_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1294,
                            "end": 1498,
                            "score": 0.5,
                            "text": "Additionally, it's important to maintain a healthy lifestyle, including a balanced diet, regular exercise, and stress management, to help control hypertension and reduce the risk of cardiovascular events.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.1303",
            "question": "What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?",
            "gold_answer": "High\u2010quality evidence shows that children and adults with a clinical diagnosis of tuberculosis (TB) meningitis receiving an anti\u2010TB regimen are less likely to die within 24 months when an adjunctive corticosteroid is administered (312 versus 413 per 1000 people died with an adjunctive corticosteroid compared with no corticosteroid, respectively). Moderate\u2010quality evidence showed that this benefit was not sustained in the longer\u2010term (5 years). Low\u2010quality evidence suggests there was no benefit of an adjunctive corticosteroid in terms of reducing rates of disabling neurological deficit, ether within 24 months or at 5 years. There was no apparent impact of adjunctive corticosteroids on the incidences of hepatitis, hyperglycemia/glycosuria, gastrointestinal bleeding, or invasive bacterial infection but event rates were very low meaning conclusions cannot be drawn.",
            "gold_answer_terms": "CLINICAL (clinical): pertaining to medical care\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.\nMENINGITIS (meningitis): Inflammation in the brain caused by a virus or bacteria.\nREGIMEN (regimen): pattern of giving treatment\nCORTICOSTEROIDS (corticosteroids): A group of hormones which may be used to suppress the body\u2019s immune response or to reduce inflammation. Also used during pregnancy in women who are thought may have their baby prematurely. They reduce the chance of the baby having problems from being born prematurely. See also steroids.\nTERM (term): Between 37 and 42 weeks of pregnancy.\nNEUROLOGICAL (neurological): pertaining to the nervous system\nGASTROINTESTINAL (gastrointestinal): Relating to the stomach and intestine.\nINVASIVE (invasive): A medical procedure when a cut is made to the body or an instrument is inserted.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.1303",
            "llm_answer": "Adjunctive corticosteroids have been shown to improve mortality and disability outcomes in people with tuberculous meningitis. Studies have consistently demonstrated that corticosteroids reduce the risk of death and disability in patients with tuberculous meningitis, particularly in those with severe disease. The use of corticosteroids has been associated with a significant reduction in mortality rates, from approximately 30-40% in untreated patients to around 10-20% in patients receiving corticosteroids. Additionally, corticosteroids have been shown to reduce the risk of long-term disability, such as hearing loss and cognitive impairment. However, the optimal dosage and duration of corticosteroid therapy for tuberculous meningitis are still uncertain and require further research.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?[/INST]",
            "topic1": [
                "child health",
                "infectious disease",
                "lungs airways"
            ],
            "topic2": [
                "respiratory infections"
            ],
            "year": 2016,
            "author": "Burch, Jane; Eisenhut, Michael"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 126,
                            "score": 0.5,
                            "text": "Adjunctive corticosteroids have been shown to improve mortality and disability outcomes in people with tuberculous meningitis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 127,
                            "end": 310,
                            "score": 0.5,
                            "text": "Studies have consistently demonstrated that corticosteroids reduce the risk of death and disability in patients with tuberculous meningitis, particularly in those with severe disease.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 311,
                            "end": 510,
                            "score": 0.5,
                            "text": "The use of corticosteroids has been associated with a significant reduction in mortality rates, from approximately 30-40% in untreated patients to around 10-20% in patients receiving corticosteroids.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 511,
                            "end": 647,
                            "score": 0.5,
                            "text": "Additionally, corticosteroids have been shown to reduce the risk of long-term disability, such as hearing loss and cognitive impairment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 648,
                            "end": 791,
                            "score": 0.5,
                            "text": "However, the optimal dosage and duration of corticosteroid therapy for tuberculous meningitis are still uncertain and require further research.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.1303",
            "question": "What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?",
            "gold_answer": "High\u2010quality evidence shows that children and adults with a clinical diagnosis of tuberculosis (TB) meningitis receiving an anti\u2010TB regimen are less likely to die within 24 months when an adjunctive corticosteroid is administered (312 versus 413 per 1000 people died with an adjunctive corticosteroid compared with no corticosteroid, respectively). Moderate\u2010quality evidence showed that this benefit was not sustained in the longer\u2010term (5 years). Low\u2010quality evidence suggests there was no benefit of an adjunctive corticosteroid in terms of reducing rates of disabling neurological deficit, ether within 24 months or at 5 years. There was no apparent impact of adjunctive corticosteroids on the incidences of hepatitis, hyperglycemia/glycosuria, gastrointestinal bleeding, or invasive bacterial infection but event rates were very low meaning conclusions cannot be drawn.",
            "gold_answer_terms": "CLINICAL (clinical): pertaining to medical care\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.\nMENINGITIS (meningitis): Inflammation in the brain caused by a virus or bacteria.\nREGIMEN (regimen): pattern of giving treatment\nCORTICOSTEROIDS (corticosteroids): A group of hormones which may be used to suppress the body\u2019s immune response or to reduce inflammation. Also used during pregnancy in women who are thought may have their baby prematurely. They reduce the chance of the baby having problems from being born prematurely. See also steroids.\nTERM (term): Between 37 and 42 weeks of pregnancy.\nNEUROLOGICAL (neurological): pertaining to the nervous system\nGASTROINTESTINAL (gastrointestinal): Relating to the stomach and intestine.\nINVASIVE (invasive): A medical procedure when a cut is made to the body or an instrument is inserted.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.1303",
            "llm_answer": "Adjunctive corticosteroids have been found to improve mortality and disability outcomes in people with tuberculous meningitis. According to a systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews, corticosteroids reduced the risk of death and disability in patients with tuberculous meningitis by 27% and 23%, respectively, compared to those who did not receive corticosteroids. However, the review also noted that the quality of the evidence was generally low and that further research is needed to confirm these findings. It's important to note that corticosteroids should only be used under the guidance of a healthcare professional and in conjunction with appropriate antituberculous therapy.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?[/INST]",
            "topic1": [
                "child health",
                "infectious disease",
                "lungs airways"
            ],
            "topic2": [
                "respiratory infections"
            ],
            "year": 2016,
            "author": "Burch, Jane; Eisenhut, Michael"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 126,
                            "score": 0.5,
                            "text": "Adjunctive corticosteroids have been found to improve mortality and disability outcomes in people with tuberculous meningitis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 127,
                            "end": 417,
                            "score": 0.5,
                            "text": "According to a systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews, corticosteroids reduced the risk of death and disability in patients with tuberculous meningitis by 27% and 23%, respectively, compared to those who did not receive corticosteroids.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 418,
                            "end": 562,
                            "score": 0.5,
                            "text": "However, the review also noted that the quality of the evidence was generally low and that further research is needed to confirm these findings.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 563,
                            "end": 735,
                            "score": 0.5,
                            "text": "It's important to note that corticosteroids should only be used under the guidance of a healthcare professional and in conjunction with appropriate antituberculous therapy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.2493",
            "question": "Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?",
            "gold_answer": "Reviewers found no conclusive RCT evidence suggesting that administration of probiotics to pregnant women was superior or inferior to placebo in reducing morbidity or mortality in preterm infants. Low\u2010certainty evidence suggests that in pregnant women who received probiotics, the risk of preterm birth (< 37 weeks) and miscarriage/stillbirth was no more or less likely compared with those who did not receive probiotics. Only one RCT (159 infants) reported no incidences of early neonatal sepsis (\u2264 3 days) in either trial arm. For most outcomes, event rates were very low or there were no events in both arms. There is a lack of data on neonatal short\u2010term (early or late sepsis, necrotizing enterocolitis, neonatal death, hospital stay) and long\u2010term (major neurodevelopmental disability) potential benefits or harms following probiotic administration. None of the trials included women with a previous history of preterm birth, multiple pregnancy, or uterine anomaly. Reviewers did not assess serious adverse maternal or neonatal adverse events following use of probiotics.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nMORBIDITY (morbidity): undesired result or complication\nMORTALITY (mortality): death\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nSEPSIS (sepsis): The immune system's overreaction to an infection or injury which can lead to tissue damage, organ failure, and death.\nPOTENTIAL (potential): possible\nPOTENTIATE (potentiate): increase or multiply the effect of a drug or toxin (poison) by giving another drug or toxin at the same time (sometimes an unintentional result)\nPOTENTIATOR (potentiator): an agent that helps another agent work better\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.2493",
            "llm_answer": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants. Studies have found that probiotics can help reduce the risk of preterm birth, necrotizing enterocolitis, and other complications in preterm infants. However, it's important to note that the efficacy of probiotics may vary depending on the specific strain and dosage used, and more research is needed to fully understand their benefits and potential risks. It's recommended to consult with a healthcare provider before taking probiotics during pregnancy.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2019,
            "author": "Kamath, Mohan S"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 122,
                            "score": 0.5,
                            "text": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 123,
                            "end": 271,
                            "score": 0.5,
                            "text": "Studies have found that probiotics can help reduce the risk of preterm birth, necrotizing enterocolitis, and other complications in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 272,
                            "end": 478,
                            "score": 0.5,
                            "text": "However, it's important to note that the efficacy of probiotics may vary depending on the specific strain and dosage used, and more research is needed to fully understand their benefits and potential risks.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 479,
                            "end": 576,
                            "score": 0.5,
                            "text": "It's recommended to consult with a healthcare provider before taking probiotics during pregnancy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.2493",
            "question": "Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?",
            "gold_answer": "Reviewers found no conclusive RCT evidence suggesting that administration of probiotics to pregnant women was superior or inferior to placebo in reducing morbidity or mortality in preterm infants. Low\u2010certainty evidence suggests that in pregnant women who received probiotics, the risk of preterm birth (< 37 weeks) and miscarriage/stillbirth was no more or less likely compared with those who did not receive probiotics. Only one RCT (159 infants) reported no incidences of early neonatal sepsis (\u2264 3 days) in either trial arm. For most outcomes, event rates were very low or there were no events in both arms. There is a lack of data on neonatal short\u2010term (early or late sepsis, necrotizing enterocolitis, neonatal death, hospital stay) and long\u2010term (major neurodevelopmental disability) potential benefits or harms following probiotic administration. None of the trials included women with a previous history of preterm birth, multiple pregnancy, or uterine anomaly. Reviewers did not assess serious adverse maternal or neonatal adverse events following use of probiotics.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nMORBIDITY (morbidity): undesired result or complication\nMORTALITY (mortality): death\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nSEPSIS (sepsis): The immune system's overreaction to an infection or injury which can lead to tissue damage, organ failure, and death.\nPOTENTIAL (potential): possible\nPOTENTIATE (potentiate): increase or multiply the effect of a drug or toxin (poison) by giving another drug or toxin at the same time (sometimes an unintentional result)\nPOTENTIATOR (potentiator): an agent that helps another agent work better\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.2493",
            "llm_answer": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants. Probiotics are beneficial bacteria that can help maintain a healthy gut microbiome, which is important for the development and function of various bodily systems, including the immune system.\nStudies have found that probiotics can help reduce the risk of preterm birth, which is a leading cause of neonatal morbidity and mortality. Probiotics have also been shown to reduce the risk of other complications in preterm infants, such as necrotizing enterocolitis, a serious condition that can cause damage to the intestines.\nIt's important to note that not all probiotics are the same, and some strains have been found to be more effective than others in preventing morbidity and mortality in preterm infants. For example, the probiotic strain Lactobacillus rhamnosus GG has been shown to be effective in reducing the risk of necrotizing enterocolitis.\nIt's important to consult with a healthcare provider before taking any supplements during pregnancy, including probiotics, to ensure safety and effectiveness. Additionally, it's important to note that while probiotics can help reduce the risk of complications, they are not a guarantee against them, and other factors such as proper prenatal care, a healthy diet, and a safe delivery are also important for a healthy pregnancy and baby.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2019,
            "author": "Kamath, Mohan S"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 122,
                            "score": 0.5,
                            "text": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 123,
                            "end": 314,
                            "score": 0.5,
                            "text": "Probiotics are beneficial bacteria that can help maintain a healthy gut microbiome, which is important for the development and function of various bodily systems, including the immune system.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 315,
                            "end": 454,
                            "score": 0.5,
                            "text": "Studies have found that probiotics can help reduce the risk of preterm birth, which is a leading cause of neonatal morbidity and mortality.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 455,
                            "end": 644,
                            "score": 0.5,
                            "text": "Probiotics have also been shown to reduce the risk of other complications in preterm infants, such as necrotizing enterocolitis, a serious condition that can cause damage to the intestines.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 645,
                            "end": 829,
                            "score": 0.5,
                            "text": "It's important to note that not all probiotics are the same, and some strains have been found to be more effective than others in preventing morbidity and mortality in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 830,
                            "end": 972,
                            "score": 0.5,
                            "text": "For example, the probiotic strain Lactobacillus rhamnosus GG has been shown to be effective in reducing the risk of necrotizing enterocolitis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 973,
                            "end": 1131,
                            "score": 0.5,
                            "text": "It's important to consult with a healthcare provider before taking any supplements during pregnancy, including probiotics, to ensure safety and effectiveness.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1132,
                            "end": 1409,
                            "score": 0.5,
                            "text": "Additionally, it's important to note that while probiotics can help reduce the risk of complications, they are not a guarantee against them, and other factors such as proper prenatal care, a healthy diet, and a safe delivery are also important for a healthy pregnancy and baby.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    }
]